Yongsheng Wang Selected Research

1-methylhydantoin

12/2022	Synthesis and Anti-Inflammatory Activity of 1-Methylhydantoin Cinnamoyl Imides.
6/2019	Antitussive and Anti-inflammatory Dual-active Agents Developed from Natural Product Lead Compound 1-Methylhydantoin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongsheng Wang Research Topics

Disease

104	Neoplasms (Cancer) 04/2024 - 02/2008
48	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 05/2010
44	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2005
32	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2008
21	Adenocarcinoma of Lung 02/2024 - 08/2012
19	Lung Neoplasms (Lung Cancer) 12/2022 - 03/2009
13	Inflammation (Inflammations) 04/2023 - 01/2009
7	Triple Negative Breast Neoplasms 04/2024 - 09/2019
7	Carcinoma (Carcinomatosis) 01/2024 - 01/2009
7	Disease Progression 12/2023 - 08/2012
7	Infections 10/2023 - 07/2013
7	Carcinogenesis 01/2017 - 01/2013
6	Malignant Pleural Effusion 02/2024 - 05/2010
6	Hypoxia (Hypoxemia) 12/2023 - 01/2014
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 12/2011
4	Residual Neoplasm 04/2024 - 04/2013
4	Neutropenia 12/2022 - 01/2020
4	Liver Neoplasms (Liver Cancer) 09/2022 - 11/2013
4	Lymphatic Metastasis 01/2022 - 03/2005
4	Pathologic Complete Response 01/2021 - 12/2018
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 09/2009
3	Adenocarcinoma 01/2024 - 01/2017
3	Hypertension (High Blood Pressure) 01/2023 - 01/2020
3	Edema (Dropsy) 01/2023 - 06/2019
3	Ischemic Stroke 03/2022 - 08/2018
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 11/2020
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 04/2008
3	Radiation Pneumonitis 06/2020 - 01/2019
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 06/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2016
3	Mastitis 04/2014 - 01/2013
2	Diarrhea 03/2024 - 12/2022
2	Pain (Aches) 02/2024 - 11/2015
2	Migraine Disorders (Migraine) 02/2024 - 07/2022
2	Exanthema (Rash) 12/2023 - 10/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 02/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2008
16	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2012
15	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2014
12	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
8	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2011
8	MicroRNAs (MicroRNA)IBA 08/2021 - 04/2013
8	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 01/2011
7	Chimeric Antigen ReceptorsIBA 09/2023 - 12/2012
7	CytokinesIBA 01/2023 - 04/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2010
7	Long Noncoding RNAIBA 08/2021 - 01/2015
7	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2009
6	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2020
6	Trastuzumab (Herceptin)FDA Link 10/2023 - 07/2015
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 05/2013
5	PlatinumIBA 04/2024 - 05/2013
5	Phosphotransferases (Kinase)IBA 01/2024 - 05/2014
5	AntigensIBA 01/2024 - 12/2012
5	Docetaxel (Taxotere)FDA Link 10/2023 - 05/2013
5	Gefitinib (Iressa)FDA Link 01/2021 - 03/2013
4	Anaplastic Lymphoma KinaseIBA 09/2023 - 10/2019
4	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2016
4	LigandsIBA 01/2023 - 08/2013
4	Hormones (Hormone)IBA 01/2023 - 05/2019
4	Peptides (Polypeptides)IBA 03/2022 - 07/2010
4	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 07/2015
4	Pemetrexed (MTA)FDA Link 07/2021 - 01/2020
4	Messenger RNA (mRNA)IBA 11/2020 - 12/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 01/2009
4	Liposomes (Liposome)IBA 07/2010 - 01/2009
3	N-acetyltalosaminuronic acid (NAT)IBA 04/2024 - 01/2021
3	Bevacizumab (Avastin)FDA Link 02/2024 - 04/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 07/2010
3	camrelizumabIBA 12/2023 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 05/2011
3	CateninsIBA 01/2023 - 06/2012
3	VaccinesIBA 01/2023 - 02/2008
3	Monoclonal AntibodiesIBA 01/2023 - 07/2022
3	Gemcitabine FDA Link 06/2022 - 03/2009
3	hetrombopagIBA 01/2022 - 11/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2015
3	Inosine Triphosphate (ITP)IBA 01/2022 - 11/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2016
3	Cancer VaccinesIBA 09/2020 - 09/2015
3	Taxoids (Taxanes)IBA 07/2020 - 11/2016
3	Cadherins (E-Cadherin)IBA 10/2018 - 06/2012
3	CollagenIBA 01/2017 - 01/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 11/2013
3	LipopolysaccharidesIBA 02/2016 - 12/2011
2	pertuzumabIBA 03/2024 - 01/2020
2	pyrotinibIBA 10/2023 - 12/2022
2	InflammasomesIBA 04/2023 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 11/2017
2	osimertinibIBA 01/2023 - 01/2022

Therapy/Procedure

50	Therapeutics 04/2024 - 04/2008
25	Drug Therapy (Chemotherapy) 02/2024 - 08/2010
23	Radiotherapy 04/2024 - 03/2005
17	Immunotherapy 04/2024 - 04/2008
11	Neoadjuvant Therapy 04/2024 - 04/2015
3	Chemoradiotherapy 06/2020 - 12/2011
2	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 01/2015
2	Punctures 12/2023 - 01/2016